- Home
- SM vs KYMR Comparison
SM vs KYMR Comparison
Compare SM & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SM | KYMR |
|---|---|---|
| Founded | 1908 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medicinal Chemicals and Botanical Products |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.3B | 7.1B |
| IPO Year | 1996 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SM | KYMR |
|---|---|---|
| Price | $32.56 | $77.36 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 26 |
| Target Price | $34.36 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 4.0M | 405.3K |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 2.56% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,154,000,000.00 | $39,211,000.00 |
| Revenue This Year | $129.01 | $10.61 |
| Revenue Next Year | $6.29 | $8.17 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.24 | N/A |
| 52 Week Low | $17.45 | $36.88 |
| 52 Week High | $35.88 | $103.00 |
Technical Indicators
Market Signals| Indicator | SM | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 37.09 |
| Support Level | $25.16 | $73.31 |
| Resistance Level | $33.25 | $77.93 |
| Average True Range (ATR) | 1.29 | 2.77 |
| MACD | -0.16 | -0.36 |
| Stochastic Oscillator | 45.35 | 1.94 |
Price Performance
Historical ComparisonAbout SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. The Company operates in the oil and gas extraction industry, focused on exploration and production activities, onshore in the United States. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, and IRAK4.